NCT05625581View on ClinicalTrials.gov

Tofatib Treatment for IgG4-related Disease

RecruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

November 10, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
IgG4-related Disease
Interventions
DRUG

tofacitinib

All subjects were treated immediately after non randomized enrollment. The treatment scheme of the experimental group: glucocorticoid+tropitib; the treatment scheme of the control group: glucocorticoid+cyclophosphamide.

Trial Locations (1)

200433

RECRUITING

Shanghai Changhai Hospital, Shanghai

All Listed Sponsors
lead

Changhai Hospital

OTHER